Market Tracker

07/25 5:16pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.5182
Delayed Data
As of 4:02pm ET
 -0.0049 / -0.94%
Today’s Change
0.47
Today|||52-Week Range
2.50
-61.04%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.52
Today’s open0.53
Day’s range0.51 - 0.53
Volume243,885
Average volume (3 months)905,731
Market cap$81.4M
Dividend yield--
Data as of 4:02pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DMPIDelMar Pharmaceutica...-0.02-0.25%
EPIXESSA Pharma Inc-0.00-0.18%
OHRPOHR Pharmaceutical I...+0.01+0.39%
CEMIChembio Diagnostics ...-1.39-16.45%
Data as of 4:00pm ET, 07/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer
Jed Andrew Latkin
Chief Scientific Officer &
Senior Vice President
Frederick O. Cope
Corporate headquarters
Dublin, Ohio

Forecasts